📈 EBV-causes-MS proof turns Epstein-Barr into a funded therapeutic target
The Harvard/US-military blood-bank paper showing Epstein-Barr infection precedes essentially every case of multiple sclerosis converts EBV from a commercially worthless nuisance ('who the hell cares about mono') into a target worth real money: T-cell therapies, mRNA vaccines, antivirals and repurposed steroids all get pulled into a newly defined, $30B-a-year indication, and Friedberg's call is that the strength of the data catalyses investment into that stack. Chamath takes the other side on healthcare economics - two-thirds of adults already carry the virus, so cost, manufacturability and ROI at population-inoculation scale get adjudicated against it.
0
CONVICTION
peaked 30.3 EMBER
DORMANT
band · contested
▲ LONG ATRA
expression · bullish equities
MISS
outcome · R -73.9% · α -62.6%
2023-01-15
window closed
⚖ Why this verdict
fully deterministic — evaluate.py replays this from daily closes; nothing below is editable or hand-set
- Window: 2022-01-15 → 2023-01-15 — first mention + 12-month horizon, then the window locks.
- The call: ▲ LONG ATRA (primary play). ATRA fell 73.9% over the window → direction-adjusted R = -73.9% (the call lost money).
- Benchmark: holding SPY over the same window returned -11.3% → α = -73.9 − (-11.3) = -62.6% — what this call made or lost against just owning the index. This is the number the verdict uses.
- Rule fired:
· HIT — R ≥ +10% AND α ≥ +5· PARTIAL — R ≥ +5% OR α ≥ 0▶ MISS — everything else
- Credit: supporters of a MISS earn 0 each, opposers the inverse — this feeds the scoreboard weights. supported: Friedberg | opposed: Chamath | proxy-sensitive: MRNA→PARTIAL (+2.9%); TAK→HIT (+10.7%); XBI→PARTIAL (-7.0%)
Conviction timeline
bands: green ≥ 65 · watch ≥ 45 · ember ≥ 15
Plays vs SPY · % since first mention (2022-01-15)
Plays
| expression | symbol | kind | relevance | rationale |
|---|---|---|---|---|
| ▲ LONG | ATRA | stock | PRIMARY | Atara Biotherapeutics is the listed pure-play on the allogeneic EBV-specific T-cell therapy modality Friedberg describes - the only instrument whose price actually responds to the EBV-MS thesis |
| ▲ LONG | MRNA | stock | adjacent | Moderna's mRNA EBV vaccine programme - the modality Jason names in-episode ('aren't we doing an mRNA vaccine for Epstein-Barr?') |
| ▲ LONG | TAK | stock | adjacent | Takeda makes maribavir, the anti-EBV antiviral Friedberg names as a possible cheap prophylactic |
| ▲ LONG | XBI | etf | adjacent | the emerging-biotech complex that absorbs the 'catalyse investment' flow into a newly validated indication |
Mention log
Friedberg
equities w=0.87 · n=120
· E63 (2022-01-15) · explicit_prediction · strength 2
▶ 1:10:36
SUPPORT
“But if Epstein-Barr virus is in fact causing this problem with MS, there's a reason to go after it, a lot of money to go after it. ... But this paper has such incredible data and such strong signal that it's really going to catalyze investment.”
Chamath
equities w=0.84 · n=160
· E63 (2022-01-15) · sentiment · strength 2
▶ 1:12:12
OPPOSE
“two-thirds of the adult population under the age of 55 have herpes simplex 4 So you're literally talking about inoculating the entire world. ... And when we start to think about that grand of a scale, there's a cost issue, there's a manufacturability issue, and then there's an ROI issue that unfortunately will be adjudicated.”
Friedberg
equities w=0.87 · n=120
· E71 (2022-03-05) · explicit_prediction · strength 2
▶ 1:23:38
SUPPORT
“including what we talked about a few weeks ago, multiple sclerosis, given that we now have a strong belief that if you can get rid of the EBV, the Epstein-Barr virus, from your body, you can wipe that out. So CAR-T can in the long run be harnessed not just for cancer, but autoimmunity”
Who built this conviction
each voice's total force on the score — supports and opposes from every mention, weighted exactly as the replay applied them · share = % of all mention-driven movement
⏳ decay drained -25.5 over the idea's life — that's time passing, attributed to no one
Score events
| episode | kind | Δ | after | note |
|---|---|---|---|---|
| E63 2022-01-15 | init | +30.3 | 30.3 | E63 born by Friedberg (explicit_prediction x2) [w=0.87] |
| E63 2022-01-15 | oppose | -10.1 | 20.3 | E63 Chamath opposes x2 [w=0.84] |
| E64 2022-01-22 | decay | -0.8 | 19.5 | E64 silent |
| E65 2022-01-29 | decay | -0.8 | 18.7 | E65 silent |
| E66 2022-02-05 | decay | -0.7 | 17.9 | E66 silent |
| E67 2022-02-12 | decay | -0.7 | 17.2 | E67 silent |
| E68 2022-02-19 | decay | -0.7 | 16.5 | E68 silent |
| E70 2022-02-24 | decay | -0.7 | 15.9 | E70 silent |
| E71 2022-03-05 | reinforce | +10.9 | 26.8 | E71 Friedberg support x2 [w=0.87] |
| E72 2022-03-19 | decay | -1.1 | 25.7 | E72 silent |
| E73 2022-03-26 | decay | -1.0 | 24.7 | E73 silent |
| E74 2022-04-01 | decay | -1.0 | 23.7 | E74 silent |
| E75 2022-04-09 | decay | -0.9 | 22.8 | E75 silent |
| E76 2022-04-16 | decay | -0.9 | 21.9 | E76 silent |
| E77 2022-04-23 | decay | -0.9 | 21.0 | E77 silent |
| E78 2022-04-30 | decay | -0.8 | 20.1 | E78 silent |
| E79 2022-05-07 | decay | -0.8 | 19.3 | E79 silent |
| E80 2022-05-13 | decay | -0.8 | 18.6 | E80 silent |
| E81 2022-05-23 | decay | -0.7 | 17.8 | E81 silent |
| E82 2022-05-24 | decay | -0.7 | 17.1 | E82 silent |
| E84 2022-06-24 | decay | -0.7 | 16.4 | E84 silent |
| E85 2022-06-30 | decay | -0.7 | 15.8 | E85 silent |
| E86 2022-07-08 | decay | -0.6 | 15.1 | E86 silent |
| E87 2022-07-14 | decay | -0.6 | 14.5 | E87 silent |
| E88 2022-07-22 | decay | -0.6 | 14.0 | E88 silent |
| E89 2022-07-29 | decay | -0.6 | 13.4 | E89 silent |
| E90 2022-08-05 | decay | -0.5 | 12.9 | E90 silent |
| E91 2022-08-13 | decay | -0.5 | 12.3 | E91 silent |
| E92 2022-08-20 | decay | -0.5 | 11.9 | E92 silent |
| E93 2022-08-26 | decay | -0.5 | 11.4 | E93 silent |
| E94 2022-09-01 | decay | -0.5 | 10.9 | E94 silent |
| E95 2022-09-10 | decay | -0.4 | 10.5 | E95 silent |
| E96 2022-09-17 | decay | -0.4 | 10.1 | E96 silent |
| E97 2022-09-23 | decay | -0.4 | 9.7 | E97 silent |
| E98 2022-10-01 | decay | -0.4 | 9.3 | E98 silent |
| E99 2022-10-07 | decay | -0.4 | 8.9 | E99 silent |
| E100 2022-10-14 | decay | -0.4 | 8.5 | E100 silent |
| E101 2022-10-22 | decay | -0.3 | 8.2 | E101 silent |
| E102 2022-10-29 | decay | -0.3 | 7.9 | E102 silent |
| E103 2022-11-05 | decay | -0.3 | 7.6 | E103 silent |
| E105 2022-11-19 | decay | -0.3 | 7.3 | E105 silent |
| E106 2022-12-03 | decay | -0.3 | 7.0 | E106 silent |
| E107 2022-12-10 | decay | -0.3 | 6.7 | E107 silent |
| E108 2022-12-16 | decay | -0.3 | 6.4 | E108 silent |
| E109 2022-12-24 | decay | -0.3 | 6.2 | E109 silent |
| E110 2023-01-06 | decay | -0.2 | 5.9 | E110 silent |
| E111 2023-01-13 | decay | -0.2 | 5.7 | E111 silent |